A detailed history of Covington Capital Management transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Covington Capital Management holds 700 shares of FLGT stock, worth $13,762. This represents 0.0% of its overall portfolio holdings.

Number of Shares
700
Previous 300 133.33%
Holding current value
$13,762
Previous $16,000 68.75%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$37.92 - $63.74 $15,168 - $25,496
400 Added 133.33%
700 $27,000
Q2 2020

Aug 13, 2020

BUY
$8.89 - $18.28 $2,667 - $5,484
300 New
300 $5,000

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $595M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Covington Capital Management Portfolio

Follow Covington Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Covington Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Covington Capital Management with notifications on news.